Cargando…

Science and Decisions: Advancing Toxicology to Advance Risk Assessment

In 2009, the National Research Council (NRC) released the latest in a series of advisory reports on human health risk assessment, titled Science and Decisions: Advancing Risk Assessment. This wide-ranging report made a number of recommendations related to risk assessment practice at the U.S. Environ...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodricks, Joseph V., Levy, Jonathan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537122/
https://www.ncbi.nlm.nih.gov/pubmed/22874419
http://dx.doi.org/10.1093/toxsci/kfs246
_version_ 1782254841758744576
author Rodricks, Joseph V.
Levy, Jonathan I.
author_facet Rodricks, Joseph V.
Levy, Jonathan I.
author_sort Rodricks, Joseph V.
collection PubMed
description In 2009, the National Research Council (NRC) released the latest in a series of advisory reports on human health risk assessment, titled Science and Decisions: Advancing Risk Assessment. This wide-ranging report made a number of recommendations related to risk assessment practice at the U.S. Environmental Protection Agency that could both influence and be influenced by evolving toxicological practice. In particular, Science and Decisions emphasized the scientific and operational necessity of a new approach for dose-response modeling; addressed the recurring challenge of defaults in risk assessment and the question of when research results can be used in place of defaults; and reinforced the value of cumulative risk assessment, which would require enhanced understanding of the joint influence of chemical and nonchemical stressors on health outcomes. The objective of this article is to summarize key messages from Science and Decisions, both as a stand-alone report and in comparison with another recent NRC report, Toxicity Testing in the 21st Century: A Vision and a Strategy. Although these reports have many conclusions in common and reinforce similar themes, there are important differences that merit careful consideration, such as the move away from apical endpoints in Toxicity Testing and the emphasis on benefit-cost analyses and related decision tools in Science and Decisions that would be strengthened by quantification of apical endpoints. Moving risk assessment forward will require toxicologists to wrestle with the implications of Science and Decisions from a toxicological perspective.
format Online
Article
Text
id pubmed-3537122
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-35371222013-01-04 Science and Decisions: Advancing Toxicology to Advance Risk Assessment Rodricks, Joseph V. Levy, Jonathan I. Toxicol Sci Forum In 2009, the National Research Council (NRC) released the latest in a series of advisory reports on human health risk assessment, titled Science and Decisions: Advancing Risk Assessment. This wide-ranging report made a number of recommendations related to risk assessment practice at the U.S. Environmental Protection Agency that could both influence and be influenced by evolving toxicological practice. In particular, Science and Decisions emphasized the scientific and operational necessity of a new approach for dose-response modeling; addressed the recurring challenge of defaults in risk assessment and the question of when research results can be used in place of defaults; and reinforced the value of cumulative risk assessment, which would require enhanced understanding of the joint influence of chemical and nonchemical stressors on health outcomes. The objective of this article is to summarize key messages from Science and Decisions, both as a stand-alone report and in comparison with another recent NRC report, Toxicity Testing in the 21st Century: A Vision and a Strategy. Although these reports have many conclusions in common and reinforce similar themes, there are important differences that merit careful consideration, such as the move away from apical endpoints in Toxicity Testing and the emphasis on benefit-cost analyses and related decision tools in Science and Decisions that would be strengthened by quantification of apical endpoints. Moving risk assessment forward will require toxicologists to wrestle with the implications of Science and Decisions from a toxicological perspective. Oxford University Press 2013-01 2012-08-08 /pmc/articles/PMC3537122/ /pubmed/22874419 http://dx.doi.org/10.1093/toxsci/kfs246 Text en © The Author 2012. Published by Oxford University Press on behalf of the Society of Toxicology. For permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Forum
Rodricks, Joseph V.
Levy, Jonathan I.
Science and Decisions: Advancing Toxicology to Advance Risk Assessment
title Science and Decisions: Advancing Toxicology to Advance Risk Assessment
title_full Science and Decisions: Advancing Toxicology to Advance Risk Assessment
title_fullStr Science and Decisions: Advancing Toxicology to Advance Risk Assessment
title_full_unstemmed Science and Decisions: Advancing Toxicology to Advance Risk Assessment
title_short Science and Decisions: Advancing Toxicology to Advance Risk Assessment
title_sort science and decisions: advancing toxicology to advance risk assessment
topic Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537122/
https://www.ncbi.nlm.nih.gov/pubmed/22874419
http://dx.doi.org/10.1093/toxsci/kfs246
work_keys_str_mv AT rodricksjosephv scienceanddecisionsadvancingtoxicologytoadvanceriskassessment
AT levyjonathani scienceanddecisionsadvancingtoxicologytoadvanceriskassessment